<DOC>
	<DOCNO>NCT00599755</DOCNO>
	<brief_summary>This study use image look tumor response combination chemotherapy gemcitabine ( Gem ) cisplatin ( Cis ) gemcitabine carboplatin ( Carbo ) non small cell lung cancer ( NSCLC ) .</brief_summary>
	<brief_title>Phase I Imaging Study Evaluating Gem/Cis Gem/Carbo Participants With Non-Small Cell Lung Cancer ( MK-0000-083 AM3 )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Has histologically cytopathologically confirm metastatic locally advanced stage IIIB/IV Nonsmall cell lung cancer ( NSCLC ) Has measurable disease Has previously treat surgery ( involve thorax ) , radiation ( unless metastatic site ) , chemotherapy NSCLC Is 18 year age older Has performance status 02 Eastern Cooperative Oncology Group ( ECOG ) scale Women childbearing potential negative pregnancy test Is participate participate study investigational compound device within 30 day 5 halflives start treatment Has untreated brain metastasis related NSCLC carcinomatous meningitis Abuses drug alcohol Is pregnant breastfeeding Is Human Immunodeficiency Virus ( HIV ) positive Has active viral hepatitis Has hearing loss Has poorly control diabetes mellitus Is allergic gemcitabine , cisplatin carboplatin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>